Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autoregulation of the MET receptor tyrosine kinase by its intracellular juxtamembrane domain. | Biochem J | 2025 | 41383124 | PubTator, text mining | PubMed |
| Does Nature Need Rights? | Oxf J Leg Stud | 2025 | 41378090 | PubTator, text mining | PubMed |
| Traceless 6-O-Lysyl Modification of N-Acetylglucosamine Enables Synthesis and Derivatization of Aggregation-Prone GlcNAcylated Peptides. | J Am Chem Soc | 2025 | 41165295 | PubTator, text mining | PubMed |
| A case report on IDH-mutant astrocytoma, CNS WHO grade 4: multi-omic characterization of untreated clinical progression. | Front Oncol | 2025 | 41079096 | PubTator, text mining | PubMed |
| In Vivo investigation of xenotransplanted human blood-derived scaffold into mice as a biodegradable construct for improvement of pelvic floor repair. | Front Bioeng Biotechnol | 2025 | 41079052 | PubTator, text mining | PubMed |
| Analysis of genetic predisposition to familial non-medullary thyroid cancer by whole genome sequencing. | Ann Endocrinol (Paris) | 2025 | 40939960 | PubTator, text mining | PubMed |
| Correction: RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer. | Br J Cancer | 2025 | 40890299 | PubTator, text mining | PubMed |
| 3D collagen high-throughput screen identifies drugs that induce epithelial polarity and enhance chemotherapy response in colorectal cancer. | Commun Biol | 2025 | 40847193 | PubTator, text mining | PubMed |
| Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer. | NPJ Precis Oncol | 2025 | 40825842 | PubTator, text mining | PubMed |
| Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights into RTK dependent and independent mechanisms. | Oncotarget | 2025 | 40560045 | PubTator, text mining | PubMed |
| Transforming Properties of E6/E7 Oncogenes from Beta-2 HPV80 in Primary Human Fibroblasts. | Int J Mol Sci | 2025 | 40508156 | PubTator, text mining | PubMed |
| Development and validation of nomogram including mutations in angiogenesis-related genes as risk factors for HCC patients treated with TACE. | Transl Oncol | 2025 | 40480146 | PubTator, text mining | PubMed |
| SDC1 is a critical transmembrane proteoglycan in breast cancer. | World J Surg Oncol | 2025 | 40380211 | PubTator, text mining | PubMed |
| Integrative multi-omics and Mendelian randomization analysis reveal SPP1+ tumor-associated macrophage-driven prognostic signature for hepatocellular carcinoma. | Front Mol Biosci | 2025 | 40376263 | PubTator, text mining | PubMed |
| RON Receptor Signaling and the Tumor Microenvironment. | Genes (Basel) | 2025 | 40282397 | PubTator, text mining | PubMed |
| Identification and validation of transcriptome-wide association study-derived genes as potential druggable targets for osteoarthritis. | Bone Joint Res | 2025 | 40079200 | PubTator, text mining | PubMed |
| Analysis of biopsies of gastric cancer, intestinal and diffuse, and non-atrophic gastritis: an overview of loss of heterozygosity in Mexican patients. | PeerJ | 2025 | 40028213 | PubTator, text mining | PubMed |
| Nuclear translocation of RON receptor tyrosine kinase. New mechanistic and functional insights. | Cytokine Growth Factor Rev | 2025 | 39794156 | PubTator, text mining | PubMed |
| Integrated analyses of transcriptomes, metabolomes, and proteomes unveil the role of FoXO signaling axis in buck semen cryopreservation. | Theriogenology | 2025 | 39756112 | PubTator, text mining | PubMed |
| MST1R Gene Variants Predispose Individuals to Tetralogy of Fallot. | Phenomics | 2024 | 40061823 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=2